
The Lancet Respiratory Medicine, Год журнала: 2024, Номер unknown
Опубликована: Дек. 1, 2024
Язык: Английский
The Lancet Respiratory Medicine, Год журнала: 2024, Номер unknown
Опубликована: Дек. 1, 2024
Язык: Английский
European Heart Journal, Год журнала: 2025, Номер unknown
Опубликована: Фев. 3, 2025
Язык: Английский
Процитировано
0Seminars in Respiratory and Critical Care Medicine, Год журнала: 2025, Номер unknown
Опубликована: Март 31, 2025
Abstract Whenever a new COVID-19 vaccination season starts, we must face challenges, including which vaccines to use, the update of high-risk groups be vaccinated, and especially type amount information communicated people in order promote vaccination. recommendations should fit these specific conditions. The use effective against predominant SARS-CoV-2 virus variants extent immune response (waning immunity) are key aspects try protect better populations. Updated currently swiftly available. However, number vaccinated with any additional booster dose is declining. Improved health training for care professionals, together tools make simpler recommendations, can encourage higher rates. Addressing challenges essential improve coverage ensure adequate protection evolving threats. has become constant presence our society. changes but neither endemic nor seasonal so far. Omicron variant prevailed nearly 2 years now several its subvariants like JN.1, KP.2, or XEC dominant ones. In this moving situation, main message same: safe effective. role current efforts mitigate severity disease reduce risk complications death, instead preventing most infections. New at different stages clinical research.
Язык: Английский
Процитировано
0International Journal of Environmental Research and Public Health, Год журнала: 2024, Номер 21(10), С. 1342 - 1342
Опубликована: Окт. 10, 2024
The aim of this paper is to assess the influence selected geographical factors on diversity development COVID-19 pandemic in Europe’s regions, and its dynamics across continent. work took into account 250 NUTS-2 regions. datasets included course (two dependent variables), intervening actions (four variables research background), potential environmental socio-economic conditioning (twelve independent variables). variables’ set was composed two indexes: morbidity temporal inertia. scope 23 March 2020–15 May 2022, with weekly resolution. By means multiple linear regression model, administrative natural assessed. Finally, a synthetic Regional Epidemic Vulnerability Index (REVI) for each individual region calculated. It allowed us classify regions three categories: resistant, neutral, or sensitive. REVI’s spatial distribution indicates that zone above-average vulnerability occurred western part Europe around Alps. Therefore, focus ought extend beyond regional statistics, towards relationships, like contiguous transit position. This also validated strong impact national borders.
Язык: Английский
Процитировано
0The Lancet Respiratory Medicine, Год журнала: 2024, Номер unknown
Опубликована: Дек. 1, 2024
Язык: Английский
Процитировано
0